Skip to content
DefDex

Federal award

NOVARTIS PHARMACEUTICALS CORPORATION

HT941026FE013

Contract

Obligated and Ceiling

Obligated (net)
$275,812.41
Ceiling (potential value, not spending)
$275,812.41
Current value
$275,812.41
Gross positive obligations
$275,812.41

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
NOVARTIS PHARMACEUTICALS CORPORATION · NG61ZA8TADW3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
NOVARTIS SANIERUNGSSTIFTUNG · YE3YG1FDWMC5
Awarding agency
Department of War · sub-agency 97DH · office HT9410
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
PIID
HT941026FE013
Parent vehicle (IDV PIID)
36F79720D0180
Award type code
C
Actions
1 · Dec 19, 2025 to Dec 19, 2025
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
Dec 19, 2025FY20260—$275,812.41
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.